+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biobanks Market - Global Forecast to 2030- Product Image
Biobanks Market - Global Forecast to 2030- Product Image
New

Biobanks Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6082867
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biobanks Market grew from USD 115.43 billion in 2024 to USD 130.56 billion in 2025. It is expected to continue growing at a CAGR of 13.49%, reaching USD 246.72 billion by 2030.

The biobanking sector has emerged as a pivotal cornerstone for modern biomedical research, underpinning breakthroughs in diagnostics, therapeutics and personalized medicine. As repositories of high-quality biological specimens and associated data, biobanks facilitate longitudinal studies, enable large-scale genomic analyses and support drug development initiatives by ensuring standardized sample handling and traceability. Recent regulatory developments, technological advancements and shifting stakeholder expectations have elevated the strategic importance of biobanks across academic, commercial and governmental spheres. Consequently, industry leaders are striving to optimize operational workflows, strengthen data management infrastructures and expand collaborative networks to maintain competitive edge. This introduction sets the stage for an in-depth exploration of the transformative forces reshaping biobanking, the emerging challenges imposed by trade policies, and strategic imperatives to thrive in a dynamic global environment.

Transformative Shifts Redefining the Biobanking Landscape

Over the past decade, the biobanking landscape has experienced profound shifts driven by digital transformation, regulatory harmonization and evolving research paradigms. Automation platforms for sample processing and ultra-low temperature storage systems now integrate with cloud-based data management tools, enabling real-time analytics and remote monitoring of sample integrity. Precision medicine initiatives have spurred greater demand for genomic-based and disease-oriented collections, while virtual biobanks-leveraging decentralized data repositories-have accelerated cross-institutional collaboration without necessitating physical specimen transfers.

Meanwhile, stricter regulatory frameworks around consent, privacy and traceability have compelled biobank operators to adopt robust governance models and blockchain-enabled audit trails. Sustainability concerns have prompted investments in energy-efficient incubators, centrifuges and temperature control systems, reducing carbon footprints. Mergers and strategic alliances are consolidating market players, fostering integrated service portfolios that span data management, sample analysis and storage & processing offerings. As a result, biobanks are transitioning from passive sample custodians to dynamic research partners, co-driving study design and translational research projects.

Assessing the 2025 US Tariff Impact on Biobanking Operations

The cumulative impact of the United States’ 2025 tariff adjustments on imported laboratory consumables, specialized equipment and reagents has introduced a new layer of complexity for biobank operators. Increased duties on temperature control systems and incubators have elevated capital expenditures, prompting procurement teams to renegotiate supplier contracts or explore alternative sourcing strategies. Tariffs on consumables, such as single-use plastics and reagents critical to sample stabilization, have further compressed operational margins.

In response, many organizations are reassessing their global supply chains, establishing dual-sourcing agreements with regional manufacturers in Europe and Asia-Pacific to mitigate cost volatility. Some have accelerated investments in modular equipment designs that allow parts to be substituted based on tariff classifications, thereby reducing duty burdens. Collaborative purchasing consortia have also emerged, enabling aggregated volume discounts and shared logistics infrastructure to offset the financial impacts of trade policy shifts. Despite these mitigation strategies, the 2025 tariff environment underscores the need for proactive risk management and agile procurement frameworks within the biobanking sector.

Key Segmentation Insights Across the Biobanking Value Chain

Segmentation analysis reveals nuanced opportunities and challenges across multiple dimensions. When examined by type, disease-oriented collections continue to dominate clinical research, genomic-based repositories are fueling precision medicine breakthroughs, population-based banks support epidemiological surveillance, and emerging virtual biobanks enhance data accessibility without incurring storage overheads.

Considering component offerings, demand for consumables remains steady, while equipment needs are evolving: alarms & monitoring systems and temperature control systems are prioritized for sample integrity, and incubators & centrifuges are essential for preparative workflows. Service portfolios are expanding, with data management solutions integrating AI-driven analytics, sample analysis services catering to multi-omics platforms, and storage & processing operations refining cryogenic logistics and transport protocols.

Sample type segmentation shows blood derivatives driving diagnostic applications, cell lines underpinning drug screening programs, nucleic acid extracts enabling genomic sequencing, and tissue specimens facilitating histopathological studies. Application-based breakdown highlights clinical diagnostics as a core revenue driver, personalized medicine initiatives spurring bespoke sample requirements, research collaborations advancing translational studies, and therapeutics pipelines relying on drug development and gene editing sample support.

Finally, end-user diversity-academic institutions, biotechnology firms, hospitals and pharmaceutical companies-necessitates tailored engagement strategies. Ownership models differentiate academic biobanks prioritizing open access, commercial biobanks focusing on turnkey service revenues, and government biobanks emphasizing public health mandates. Together, these segmentation insights illuminate pathways for targeted investment, customized service design and strategic partnerships.

Regional Variations Shaping Biobanking Growth

Regional dynamics continue to shape the global biobanking ecosystem. In the Americas, strong funding for precision medicine projects and widespread adoption of standardized consent frameworks have driven rapid growth in both academic and commercial repositories. The presence of major pharmaceutical hubs and innovative biotechnology clusters supports comprehensive service offerings, from sample sourcing to multi-omics data analysis.

Meanwhile, Europe, Middle East & Africa leverage harmonized regulatory guidelines such as GDPR to ensure data privacy and interoperability across cross-border collaborations. Public-private partnerships in this region have modernized national biobank networks, enhancing population-based studies and facilitating large-scale genetics research. Energy-efficient storage solutions and service diversification are key focal areas.

In Asia-Pacific, burgeoning research investments in China, Japan and Australia are fueling the expansion of genomic-based and disease-oriented collections. Rapidly improving infrastructure, coupled with government incentives for biotech innovation, has accelerated the adoption of automated systems and advanced data management platforms. However, regulatory heterogeneity and logistical challenges in remote areas necessitate bespoke operational models. Collectively, these regional insights underscore the importance of localized strategies to address regulatory, infrastructural and cultural nuances.

Competitive Landscape: Innovators and Integrators in Biobanking

Leading organizations are differentiating through innovation in technology, service integration and strategic alliances. Acorn Biolabs, Inc. and Avantor, Inc. are enhancing consumable portfolios with proprietary stabilization reagents, while AMS Biotechnology (Europe) Limited and Artizan Biosciences, Inc. collaborate on custom sample analysis workflows. ASKION GmbH has optimized its equipment lineup around modular incubators and centrifuges, and Bay Biosciences LLC is extending storage & processing capabilities through cryogenic transport solutions.

Large conglomerates such as Beckman Coulter, Inc. by Danaher Corporation and Thermo Fisher Scientific Inc. leverage scale to offer end-to-end service ecosystems, integrating alarms & monitoring systems with data management platforms. Becton, Dickinson and Company and Qiagen N.V. focus on nucleic acid extraction kits and automated processing instruments to serve high-throughput applications. BioIVT LLC and BioLife Solutions Inc. are advancing cell line repositories with enhanced quality control protocols, while Charles River Laboratories International, Inc. and Provia Laboratories, LLC provide comprehensive sample analysis and translational research services.

Cryoport Systems, LLC and Taylor-Wharton have strengthened cold chain logistics, and Hamilton Company and Tecan Trading AG offer lab automation systems designed for scalable workflows. BioKryo by L’AIR LIQUIDE S.A. and Micronic Holding B.V. are innovating in cryogenic storage hardware, whereas BocaBio, CTIBiotech and ProteoGenex, Inc. specialize in custom biobank solutions. Shanghai Outdo Biotech Co. Ltd and UK Biobank Limited represent leading players in regional repository networks, collectively illustrating the diverse strategies driving advancement in the biobanking domain.

Actionable Recommendations for Sustained Competitive Advantage

Industry leaders should prioritize five strategic initiatives to remain ahead. First, invest in interoperable data platforms that harmonize clinical, genomic and operational datasets, enabling real-time decision-making and accelerating translational research. Second, develop modular procurement strategies incorporating dual sourcing and tariff-aware equipment configurations to mitigate trade risk and control capital outlays. Third, expand service portfolios by integrating AI-driven analytics, advanced sample processing and end-to-end cold chain logistics, thereby delivering differentiated value to end users. Fourth, cultivate strategic alliances across academic, commercial and governmental domains to leverage complementary expertise, share infrastructure costs and co-create novel research initiatives. Finally, adopt sustainability frameworks, focusing on energy-efficient storage units and green consumables, to align with global environmental goals and appeal to ESG-conscious stakeholders. By executing these actions, organizations will reinforce resilience, unlock new revenue streams and solidify their role as indispensable partners in biomedical innovation.

Conclusion: Maximizing Biobank Potential Through Strategic Innovation

The evolution of biobanking reflects an intersection of technological innovation, regulatory complexity and shifting research imperatives. As digital transformation accelerates and precision medicine becomes mainstream, biobanks are positioned to deliver unprecedented value by harmonizing specimen stewardship with advanced data analytics. However, external pressures-from evolving trade policies to region-specific regulatory requirements-necessitate adaptive strategies and robust governance frameworks.

By integrating modular procurement, expanding service offerings and forging strategic collaborations, biobank operators can navigate uncertainties and capitalize on emerging research trends. As the industry matures, those who embrace sustainability, data interoperability and customer-centric innovation will not only enhance operational efficiency but also contribute more effectively to global health outcomes. Ultimately, the future of biobanking lies in its ability to serve as a catalyst for scientific discovery, driving breakthroughs that translate into improved diagnostics, therapies and public health initiatives.

Market Segmentation & Coverage

This research report categorizes the Biobanks Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Disease-Oriented
  • Genomic-Based
  • Population-Based
  • Virtual
  • Consumables
  • Equipment
    • Alarms & Monitoring Systems
    • Incubators & Centrifuges
    • Temperature Control Systems
  • Services
    • Data Management
    • Sample Analysis
    • Storage & Processing
    • Transpost
  • Blood Derivatives
  • Cell Lines
  • Nucleic Acid
  • Tissues
  • Clinical Diagnostics
  • Personalized Medicine
  • Research
  • Therapeutics
    • Drug Development
    • Gene Editing
  • Academic Institutions
  • Biotechnology Companies
  • Hospitals
  • Pharmaceutical Companies
  • Academic Biobanks
  • Commercial Biobanks
  • Government Biobanks

This research report categorizes the Biobanks Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biobanks Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Acorn Biolabs, Inc.
  • AMS Biotechnology (Europe) Limited
  • Artizan Biosciences, Inc.
  • ASKION GmbH
  • Avantor, Inc.
  • Bay Biosciences LLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • BioIVT LLC
  • BioKryo by L’AIR LIQUIDE S.A.
  • BioLife Solutions Inc.
  • BocaBio
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBiotech
  • Cureline, Inc.
  • Firalis Group
  • Greiner AG
  • Hamilton Company
  • LVL Technologies GmbH & Co. KG
  • Merck KGaA
  • Micronic Holding B.V.
  • ProteoGenex, Inc.
  • Provia Laboratories, LLC
  • Qiagen N.V.
  • Shanghai Outdo Biotech Co. Ltd
  • Taylor-Wharton
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biobanks Market, by Type
8.1. Introduction
8.2. Disease-Oriented
8.3. Genomic-Based
8.4. Population-Based
8.5. Virtual
9. Biobanks Market, by Component
9.1. Introduction
9.2. Consumables
9.3. Equipment
9.3.1. Alarms & Monitoring Systems
9.3.2. Incubators & Centrifuges
9.3.3. Temperature Control Systems
9.4. Services
9.4.1. Data Management
9.4.2. Sample Analysis
9.4.3. Storage & Processing
9.4.4. Transpost
10. Biobanks Market, by Sample Type
10.1. Introduction
10.2. Blood Derivatives
10.3. Cell Lines
10.4. Nucleic Acid
10.5. Tissues
11. Biobanks Market, by Application
11.1. Introduction
11.2. Clinical Diagnostics
11.3. Personalized Medicine
11.4. Research
11.5. Therapeutics
11.5.1. Drug Development
11.5.2. Gene Editing
12. Biobanks Market, by End User
12.1. Introduction
12.2. Academic Institutions
12.3. Biotechnology Companies
12.4. Hospitals
12.5. Pharmaceutical Companies
13. Biobanks Market, by Ownership
13.1. Introduction
13.2. Academic Biobanks
13.3. Commercial Biobanks
13.4. Government Biobanks
14. Americas Biobanks Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Biobanks Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Biobanks Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Acorn Biolabs, Inc.
17.3.2. AMS Biotechnology (Europe) Limited
17.3.3. Artizan Biosciences, Inc.
17.3.4. ASKION GmbH
17.3.5. Avantor, Inc.
17.3.6. Bay Biosciences LLC
17.3.7. Beckman Coulter, Inc. by Danaher Corporation
17.3.8. Becton, Dickinson and Company
17.3.9. BioIVT LLC
17.3.10. BioKryo by L’AIR LIQUIDE S.A.
17.3.11. BioLife Solutions Inc.
17.3.12. BocaBio
17.3.13. Charles River Laboratories International, Inc.
17.3.14. Cryoport Systems, LLC
17.3.15. CTIBiotech
17.3.16. Cureline, Inc.
17.3.17. Firalis Group
17.3.18. Greiner AG
17.3.19. Hamilton Company
17.3.20. LVL Technologies GmbH & Co. KG
17.3.21. Merck KGaA
17.3.22. Micronic Holding B.V.
17.3.23. ProteoGenex, Inc.
17.3.24. Provia Laboratories, LLC
17.3.25. Qiagen N.V.
17.3.26. Shanghai Outdo Biotech Co. Ltd
17.3.27. Taylor-Wharton
17.3.28. Tecan Trading AG
17.3.29. Thermo Fisher Scientific Inc.
17.3.30. UK Biobank Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOBANKS MARKET MULTI-CURRENCY
FIGURE 2. BIOBANKS MARKET MULTI-LANGUAGE
FIGURE 3. BIOBANKS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOBANKS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOBANKS MARKET SIZE, BY ALARMS & MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPOST, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOBANKS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOBANKS MARKET SIZE, BY COMMERCIAL BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOBANKS MARKET SIZE, BY GOVERNMENT BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 121. CHINA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. CHINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. CHINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 124. CHINA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. CHINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 126. CHINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. CHINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 128. CHINA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. CHINA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 130. INDIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. INDIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 132. INDIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 133. INDIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 134. INDIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 135. INDIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. INDIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 137. INDIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. INDIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 148. JAPAN BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. JAPAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 150. JAPAN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 151. JAPAN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 152. JAPAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 153. JAPAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. JAPAN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 155. JAPAN BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. JAPAN BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 202. THAILAND BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. THAILAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 204. THAILAND BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 205. THAILAND BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 206. THAILAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 207. THAILAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. THAILAND BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 209. THAILAND BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. THAILAND BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 230. DENMARK BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. DENMARK BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 232. DENMARK BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 233. DENMARK BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 234. DENMARK BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 235. DENMARK BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. DENMARK BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 237. DENMARK BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. DENMARK BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 239. EGYPT BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. EGYPT BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 241. EGYPT BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 242. EGYPT BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 243. EGYPT BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 244. EGYPT BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. EGYPT BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. EGYPT BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 248. FINLAND BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. FINLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 250. FINLAND BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 251. FINLAND BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 252. FINLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 253. FINLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. FINLAND BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 255. FINLAND BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. FINLAND BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 257. FRANCE BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 259. FRANCE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 260. FRANCE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 261. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 262. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. FRANCE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 264. FRANCE BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. FRANCE BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 266. GERMANY BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 268. GERMANY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 269. GERMANY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 270. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 271. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. GERMANY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 273. GERMANY BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. GERMANY BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 284. ITALY BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 286. ITALY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 287. ITALY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 288. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 289. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. ITALY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 291. ITALY BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. ITALY BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 311. NORWAY BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. NORWAY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 313. NORWAY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 314. NORWAY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 315. NORWAY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 316. NORWAY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. NORWAY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 318. NORWAY BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. NORWAY BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 320. POLAND BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 321. POLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 322. POLAND BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 323. POLAND BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 324. POLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 325. POLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. POLAND BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 327. POLAND BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. POLAND BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 329. QATAR BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 330. QATAR BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 331. QATAR BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 332. QATAR BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 333. QATAR BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 334. QATAR BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. QATAR BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 336. QATAR BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. QATAR BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 338. RUSSIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 339. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 340. RUSSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 341. RUSSIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 342. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 343. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. RUSSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 345. RUSSIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 346. RUSSIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 348. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 350. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 352. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 354. SAUDI ARABIA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 356. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 358. SOUTH AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 359. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 360. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 361. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 362. SOUTH AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 363. SOUTH AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 364. SOUTH AFRICA BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 365. SPAIN BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 366. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 367. SPAIN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 368. SPAIN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 369. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 370. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 371. SPAIN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 372. SPAIN BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 373. SPAIN BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 374. SWEDEN BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 375. SWEDEN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 376. SWEDEN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 377. SWEDEN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 378. SWEDEN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 379. SWEDEN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 380. SWEDEN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 381. SWEDEN BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 382. SWEDEN BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 383. SWITZERLAND BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 384. SWITZERLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 385. SWITZERLAND BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 386. SWITZERLAND BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 387. SWITZERLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 388. SWITZERLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 389. SWITZERLAND BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 390. SWITZERLAND BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 391. SWITZERLAND BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 392. TURKEY BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 393. TURKEY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 394. TURKEY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 395. TURKEY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 396. TURKEY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 397. TURKEY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 398. TURKEY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 399. TURKEY BIOBANKS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 400. TURKEY BIOBANKS MARKET SIZE, BY OWNERSHIP, 2018-2030 (USD MILLION)
TABLE 401. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 402. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 403. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 404. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 405. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY S

Companies Mentioned

  • Acorn Biolabs, Inc.
  • AMS Biotechnology (Europe) Limited
  • Artizan Biosciences, Inc.
  • ASKION GmbH
  • Avantor, Inc.
  • Bay Biosciences LLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • BioIVT LLC
  • BioKryo by L’AIR LIQUIDE S.A.
  • BioLife Solutions Inc.
  • BocaBio
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBiotech
  • Cureline, Inc.
  • Firalis Group
  • Greiner AG
  • Hamilton Company
  • LVL Technologies GmbH & Co. KG
  • Merck KGaA
  • Micronic Holding B.V.
  • ProteoGenex, Inc.
  • Provia Laboratories, LLC
  • Qiagen N.V.
  • Shanghai Outdo Biotech Co. Ltd
  • Taylor-Wharton
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biobanking Market Overview, 2024-2029 - Product Image

Biobanking Market Overview, 2024-2029

  • Report
  • 128 Pages
  • Global
From
Biobanks - Global Strategic Business Report - Product Image

Biobanks - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033 - Product Image

Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From

About the Biobank Market

The Biobank market is a subset of the biotechnology industry that focuses on the collection, storage, and distribution of biological samples for research purposes. These samples can include human tissue, blood, and other bodily fluids, as well as plant and animal tissue. The biobank market is driven by the need for high-quality biological samples for research and development in the biotechnology industry. Biobanks are used to store and distribute biological samples for a variety of research purposes, including drug discovery, diagnostics, and personalized medicine. They are also used to store and distribute samples for clinical trials and epidemiological studies. The biobank market is highly competitive, with a number of companies offering services such as sample collection, storage, and distribution. Some of the major players in the market include Thermo Fisher Scientific, Qiagen, BioStorage Technologies, and Brooks Life Sciences. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.